相似文献
1
Pathogenesis of Bacterial Vaginosis: Discussion of Current Hypotheses.
J Infect Dis. 2016 Aug 15;214 Suppl 1(Suppl 1):S1-5. doi: 10.1093/infdis/jiw121.
2
Prevalence and distribution of Gardnerella vaginalis subgroups in women with and without bacterial vaginosis.
BMC Infect Dis. 2017 Jun 5;17(1):394. doi: 10.1186/s12879-017-2501-y.
3
Role of Gardnerella vaginalis in the pathogenesis of bacterial vaginosis: a conceptual model.
J Infect Dis. 2014 Aug 1;210(3):338-43. doi: 10.1093/infdis/jiu089. Epub 2014 Feb 7.
4
[Risk factors for bacterial vaginosis - a 3-year study in four medical centers].
Akush Ginekol (Sofiia). 2014;53(3):8-12.
5
Gardnerella vaginalis diversity and ecology in relation to vaginal symptoms.
Res Microbiol. 2017 Nov-Dec;168(9-10):837-844. doi: 10.1016/j.resmic.2017.02.011. Epub 2017 Mar 22.
6
Gardnerella vaginalis Clade Distribution Is Associated With Behavioral Practices and Nugent Score in Women Who Have Sex With Women.
J Infect Dis. 2020 Jan 14;221(3):454-463. doi: 10.1093/infdis/jiz474.
7
Recent progress in understanding the epidemiology of bacterial vaginosis.
Curr Opin Obstet Gynecol. 2014 Dec;26(6):448-54. doi: 10.1097/GCO.0000000000000112.
8
The aetiology of bacterial vaginosis.
J Appl Microbiol. 2011 May;110(5):1105-28. doi: 10.1111/j.1365-2672.2011.04977.x. Epub 2011 Mar 14.
9
Using an in-vitro biofilm model to assess the virulence potential of bacterial vaginosis or non-bacterial vaginosis Gardnerella vaginalis isolates.
Sci Rep. 2015 Jun 26;5:11640. doi: 10.1038/srep11640.
10
Comparative analysis of virulence factors & biotypes of isolated from the genital tract of women with & without bacterial vaginosis.
Indian J Med Res. 2019 Jan;149(1):57-61. doi: 10.4103/ijmr.IJMR_1674_16.
引用本文的文献
1
Endolysin selectively kills Gardnerella ex vivo in vaginal samples from women with bacterial vaginosis.
NPJ Biofilms Microbiomes. 2025 Aug 12;11(1):161. doi: 10.1038/s41522-025-00764-0.
2
Vaginal pharmacomicrobiomics modulates risk of persistent and recurrent bacterial vaginosis.
NPJ Biofilms Microbiomes. 2025 Jul 1;11(1):115. doi: 10.1038/s41522-025-00748-0.
3
Bacterial vaginosis.
Nat Rev Dis Primers. 2025 Jun 19;11(1):43. doi: 10.1038/s41572-025-00626-1.
4
In Vitro Bactericidal Activity of a Neomycin-Polymyxin B-Nystatin Combination Compared to Metronidazole and Clindamycin Against the Main Bacteria Involved in Bacterial Vaginosis and Aerobic Vaginitis.
Pharmaceuticals (Basel). 2025 Feb 27;18(3):340. doi: 10.3390/ph18030340.
5
Metronidazole response profiles of Gardnerella species are congruent with phylogenetic and comparative genomic analyses.
Genome Med. 2025 Mar 25;17(1):28. doi: 10.1186/s13073-025-01446-4.
6
Gardnerella Species and Their Association With Bacterial Vaginosis.
J Infect Dis. 2024 Jul 25;230(1):e171-e181. doi: 10.1093/infdis/jiae026.
7
Optimized bacterial absolute quantification method by qPCR using an exogenous bacterial culture as a normalization strategy in triple-species BV-like biofilms.
J Microbiol Methods. 2024 Apr;219:106895. doi: 10.1016/j.mimet.2024.106895. Epub 2024 Feb 6.
8
Investigating Oxidative Stress Levels in Pregnant Patients Infected with Hepatitis C Virus and Bacterial Vaginosis for Better Treatment Option.
Oman Med J. 2023 Sep 28;38(5):e549. doi: 10.5001/omj.2023.102. eCollection 2023 Sep.
9
Functional data analysis to characterize disease patterns in frequent longitudinal data: application to bacterial vaginal microbiota patterns using weekly Nugent scores and identification of pattern-specific risk factors.
BMC Med Res Methodol. 2023 Oct 26;23(1):251. doi: 10.1186/s12874-023-02063-8.
10
Cervicovaginal Gardnerella sialidase-encoding gene in persistent human papillomavirus infection.
Sci Rep. 2023 Aug 31;13(1):14266. doi: 10.1038/s41598-023-41469-8.
本文引用的文献
1
Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines.
Clin Infect Dis. 2015 Dec 15;61 Suppl 8:S759-62. doi: 10.1093/cid/civ771.
2
A cross-sectional study of bacterial vaginosis, intravaginal practices and HIV genital shedding; implications for HIV transmission and women's health.
BMJ Open. 2015 Nov 9;5(11):e009036. doi: 10.1136/bmjopen-2015-009036.
3
Vaginal biogenic amines: biomarkers of bacterial vaginosis or precursors to vaginal dysbiosis?
Front Physiol. 2015 Sep 29;6:253. doi: 10.3389/fphys.2015.00253. eCollection 2015.
4
Biofilms: An Underappreciated Mechanism of Treatment Failure and Recurrence in Vaginal Infections.
Clin Infect Dis. 2015 Aug 15;61(4):601-6. doi: 10.1093/cid/civ353. Epub 2015 May 1.
5
Vaginal microbiota of adolescent girls prior to the onset of menarche resemble those of reproductive-age women.
mBio. 2015 Mar 24;6(2):e00097-15. doi: 10.1128/mBio.00097-15.
6
Periodontitis: from microbial immune subversion to systemic inflammation.
Nat Rev Immunol. 2015 Jan;15(1):30-44. doi: 10.1038/nri3785.
7
Differences in vaginal microbiome in African American women versus women of European ancestry.
Microbiology (Reading). 2014 Oct;160(Pt 10):2272-2282. doi: 10.1099/mic.0.081034-0. Epub 2014 Jul 29.
8
Role of Gardnerella vaginalis in the pathogenesis of bacterial vaginosis: a conceptual model.
J Infect Dis. 2014 Aug 1;210(3):338-43. doi: 10.1093/infdis/jiu089. Epub 2014 Feb 7.
9
Suspected heterosexual transmission of bacterial vaginosis without seminal fluid exposure.
Sex Transm Dis. 2014 Jan;41(1):58-60. doi: 10.1097/OLQ.0000000000000057.
10
Infection through structured polymicrobial Gardnerella biofilms (StPM-GB).
Histol Histopathol. 2014 May;29(5):567-87. doi: 10.14670/HH-29.10.567. Epub 2013 Dec 11.
Zotero 插件